Skip to main content

Table 4 Cytotoxicity of L-OHP on OCUM-2MD3/L-OHP (μg/mL, %, x ¯ ± s, 48 h).

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Group 600 300 150 75 37.5 IC50
OCUM-2MD3 85.2 ± 0.9 74.6 ± 1.7 65.4 ± 2.1 51.2 ± 1.4 37.3 ± 2.2 71.2
OCUM-2MD3/L-OHP 72.4 ± 1.5* 52.7 ± 2.6* 43.5 ± 0.8* 26.4 ± 1.5* 9.8 ± 3.2* 235.2
  1. *Compared with OCUM-2MD3 Group P < 0.05